|
Genetics of Appendix Cancer Study
RECRUITINGSponsored by Andreana Holowatyj, PhD, MSCI
Actively Recruiting
SponsorAndreana Holowatyj, PhD, MSCI
Started2022-11-11
Est. completion2032-11
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT05734430
Summary
The GAP Study is a prospective cohort study designed to comprehensively investigate genetic variations that may contribute to cancer development among individuals diagnosed with appendix/appendiceal cancer who are ages 18+ years.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: GAP Social * Known diagnosis of appendix cancer in the United States * Mentally and physically able to consent and participate in the study GAP Vanderbilt * Known diagnosis of appendix cancer * Diagnosed by and/or consulting with a physician/clinical provider participating in the GAP Study * Mentally and physically able to consent and participate in the study GAP Parent * Biological parents (mother and/or father) of individuals actively participating in the GAP Study * Residing in the United States * Mentally and physically able to consent and participate in the study Exclusion Criteria: * Women pregnant at the time of consent * Prisoners * Unable to provide informed consent * Unable to read, write, or complete questionnaires in English
Conditions16
Appendiceal AdenocarcinomaAppendiceal CancerAppendiceal Carcinoid TumorAppendiceal Mucinous NeoplasmAppendiceal Neoplasm Malignant SecondaryAppendiceal NeoplasmsAppendix AdenocarcinomaAppendix CancerAppendix Cancer MetastaticAppendix Mucinous Neoplasm
Locations1 site
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, 37232
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorAndreana Holowatyj, PhD, MSCI
Started2022-11-11
Est. completion2032-11
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT05734430